Evaluation of Biological Properties In-Vivo of Poly(L-Lactide-Coglycolide) Composites Containing Bioactive Glass
Source abstract
Abstract
To evaluate the biological safety of composite materials based on poly(L-lactide-co-glycolide) (PLGA) and bioactive glass (BG), which have a potential application in tissue engineering, the in-vivo biological properties were investigated by applying the micronucleus test, acute systemic toxicity test, haemolytic test and pyrogen measurement. The results indicated that the PLGA/BG composite showed no genetic toxicity; there was no toxicosis or death observed in the acute systemic toxicity test. The haemolytic test suggested that the PLGA/BG composite, with a haemolytic index of 0.281%, did not have an obvious haemolytic reaction. In addition, the PLGA/BG composite materials showed no pyrogen reaction. Therefore, PLGA/BG composite materials could be promising candidate biomedical materials for bone tissue engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Facial Trauma and Fracture Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Theoretical Chemistry and Molecular Simulation of Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, P. R. China
Department of Orthopedics, the Second Xiangya Hospital, Central South University, Changsha, P.R.China
References (20)
Show source-provided references
1. 10.1007/s10856-004-5740-610.1007/s10856-004-5740-6 ↗
2. 10.1016/j.biomaterials.2008.04.01010.1016/j.biomaterials.2008.04.010 ↗
3. 10.1080/0360255100366461010.1080/03602551003664610 ↗
4. 10.1007/s10856-007-3292-210.1007/s10856-007-3292-2 ↗
5. 10.1016/j.polymdegradstab.2008.07.00710.1016/j.polymdegradstab.2008.07.007 ↗
6. 10.1080/0360255090282452310.1080/03602550902824523 ↗
7. 10.1002/jbm.a.3004310.1002/jbm.a.30043 ↗
8. 10.1016/j.biomaterials.2003.09.08110.1016/j.biomaterials.2003.09.081 ↗
9. 10.1002/jbm.1024810.1002/jbm.10248 ↗
10. 10.1080/0022234100359842210.1080/00222341003598422 ↗
11. 10.1080/0360255090309253410.1080/03602550903092534 ↗
12. 10.1080/0360255080194627810.1080/03602550801946278 ↗
13. 10.1080/0360255090353213310.1080/03602550903532133 ↗
14. 10.1016/j.msec.2005.08.00410.1016/j.msec.2005.08.004 ↗
15. 10.3109/0309190100375304110.3109/03091901003753041 ↗
16. 10.1177/09673911110190091010.1177/096739111101900910 ↗
17. 10.1007/s00289-009-0149-510.1007/s00289-009-0149-5 ↗
18. 10.4028/www.scientific.net/MSF.685.38410.4028/www.scientific.net/MSF.685.384 ↗
19. ISO 10993 Part 11. Tests for systemic toxicity. International Organization for Standardization Geneva Switzerland. 2006.
20. ISO 10993 Part 4. Selection of tests for interaction with blood. International Standard Organization Geneva Switzerland. 1992.